Press Release R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis R1 Therapeutics · Jul 21
Press Release Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T Tempest Therapeutics · Jul 21
Press Release Talisker Reports Mustang Underground Face Sample Results and Defines a 127 metre Strike Length High-grade Shoot Averaging 22 g/t on the 1045 Level including 610 g/t over 0.51 of a metre Talisker Resources Ltd. · Jul 21
Press Release Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer Altesa Biosciences Inc. · Jul 21
Press Release Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis Nektar Therapeutics · Jul 21
Press Release Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia Alebund Pharmaceuticals · Jul 21
Press Release Bonkers Toys to Launch New Aphmau Toys at Retail Including a MyStreet line and Cat Café Playset Bonkers Toys · Jul 21
Press Release NorthRock Partners Expands Minneapolis Presence with Addition of Kowalski Financial, Strengthening National Growth Strategy NorthRock Partners · Jul 21
Press Release Imagine360 and Health Rosetta Launch Integrated Health Plan for Employers Facing Record Cost Increases Imagine360 · Jul 21
Press Release RTX’s Pratt & Whitney Canada advances hybrid-electric technology development RTX · Jul 21